Investment Community Webcast Link Jul 22, 202
Post# of 155139
(Total Views: 892)
Posted On: 07/22/2021 10:18:34 AM
Investment Community Webcast Link
Jul 22, 2021 • 1:00 pm PDT
Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Christopher Recknor, M.D., Chief Operating Officer and Head of Clinical Development, will host an investment community webcast on Thursday, July 22, 2021.
Management will provide a full discussion of the results from the recently reported data from the mTNBC trials, along with updates on cancer, COVID-19, and NASH trials, and the status of the resubmission of the BLA for HIV.
Management will provide approximately 60 minutes to address questions submitted online by analysts and investors.
Date: Thursday, July 22, 2021
Time: 1:00 pm PT / 4:00 pm ET
Dial-In: None
Questions:
Prior to the webcast, questions can be submitted online to ir@cytodyn.com.
During the webcast, questions can be submitted through the webcast link below.
This is a “listen only” webcast, which can be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 30 days. Participants are encouraged to go to the website 15 minutes prior to the start of the webcast to register, download and install any necessary software. Please note the below website will not be operational until approximately 60 minutes prior to the start of the webcast, which can be accessed via the following link:
https://78449.themediaframe.com/dataconf/prod...ndexl.html
Jul 22, 2021 • 1:00 pm PDT
Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Christopher Recknor, M.D., Chief Operating Officer and Head of Clinical Development, will host an investment community webcast on Thursday, July 22, 2021.
Management will provide a full discussion of the results from the recently reported data from the mTNBC trials, along with updates on cancer, COVID-19, and NASH trials, and the status of the resubmission of the BLA for HIV.
Management will provide approximately 60 minutes to address questions submitted online by analysts and investors.
Date: Thursday, July 22, 2021
Time: 1:00 pm PT / 4:00 pm ET
Dial-In: None
Questions:
Prior to the webcast, questions can be submitted online to ir@cytodyn.com.
During the webcast, questions can be submitted through the webcast link below.
This is a “listen only” webcast, which can be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 30 days. Participants are encouraged to go to the website 15 minutes prior to the start of the webcast to register, download and install any necessary software. Please note the below website will not be operational until approximately 60 minutes prior to the start of the webcast, which can be accessed via the following link:
https://78449.themediaframe.com/dataconf/prod...ndexl.html
(0)
(0)